What's new? Log in Free sign up

Bellerophon Therapeutics (BLPH) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Air Air quality Environment Environmental Materials Natural Resources Nature Offset Package Packaging Pandemic Plastic Raw Materials Regenerative Toxic Waste Access African American Asian Benefits Black Charitable Collective Bargaining Community Culture Customer Cyber Cybersecurity Death Demographic Disability Diversity Drug Pricing Employee Employee Retention Engagement Ethnicity Gender Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Resources Incident Injuries Injury Latinx LGBTQ Privacy Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skills Social Society Stakeholder Supplier Supply Chain Training Union Women Workers Assessment Assurance Audit Bonus Chronic Classified Classified Board Commitment Corporate Governance Corporate Purpose Corruption Department of Ethics Executive Compensation Expert Fraud Goals Governance Incentive Incentivize Independence Independent Innovation Innovative Investigation Lawsuit Leadership Litigation Long-term Majority Materiality Oversee Oversight Procurement Proxy Access Purpose Quality Standard R&D Recoup Reputation Reputational Research and Development Responsibility Responsible Special Meeting Strategy Sustainability Tax Tenure Transparency

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.